Clinical Trial Update: Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) [Phase 3]

View source ↗

Summary

Phase 3 CASSANDRA trial compares short-course vs long-course preoperative chemotherapy with mFOLFIRINOX or PAXG in pancreatic ductal adenocarcinoma. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• PAXG
• mFOLFIRINOX

Snippet

Sponsor: Associazione Italiana per lo Studio del Pancreas | Conditions: Pancreas Ductal Adenocarcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING